Log In
Print
BCIQ
Print
Print this Print this
 

Advate, octocog alfa

Also known as: Recombinant Factor VIII (Factor VIII - protein-free method (rAHF-PFM)) (rAHF-PFM)

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionRecombinant Factor VIII (rFVIII)
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsTreat bleeding in patients with hemophilia A
Regulatory Designation

Partner

Baxter International Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today